<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR145">
 <label>145.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Peng</surname>
    <given-names>F</given-names>
   </name>
   <name>
    <surname>Xiong</surname>
    <given-names>L</given-names>
   </name>
   <name>
    <surname>Xie</surname>
    <given-names>X</given-names>
   </name>
   <name>
    <surname>Tang</surname>
    <given-names>H</given-names>
   </name>
   <name>
    <surname>Huang</surname>
    <given-names>R</given-names>
   </name>
   <name>
    <surname>Peng</surname>
    <given-names>C</given-names>
   </name>
  </person-group>
  <article-title>Isoliquiritigenin derivative regulates miR-374a/BAX axis to suppress triple-negative breast cancer tumorigenesis and development</article-title>
  <source>Front Pharmacol</source>
  <year>2020</year>
  <volume>11</volume>
  <fpage>378</fpage>
  <pub-id pub-id-type="doi">10.3389/fphar.2020.00378</pub-id>
  <?supplied-pmid 32296334?>
  <pub-id pub-id-type="pmid">32296334</pub-id>
 </element-citation>
</ref>
